Cargando…
Latent TGF-β1 protects against diabetic kidney disease via Arkadia/Smad7 signaling
TGF-β1 has long been considered as a key mediator in diabetic kidney disease (DKD) but anti-TGF-β1 treatment fails clinically, suggesting a diverse role for TGF-β1 in DKD. In the present study, we examined a novel hypothesis that latent TGF-β1 may be protective in DKD mice overexpressing human laten...
Autores principales: | Wu, Weifeng, Huang, Xiao R., You, Yongke, Xue, Liang, Wang, Xiao-Jing, Meng, Xiaoming, Lin, Xiang, Shen, Jiangang, Yu, Xueqing, Lan, Hui-Yao, Chen, Haiyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416717/ https://www.ncbi.nlm.nih.gov/pubmed/34512167 http://dx.doi.org/10.7150/ijbs.61647 |
Ejemplares similares
-
Arkadia Enhances Nodal/TGF-β Signaling by Coupling Phospho-Smad2/3 Activity and Turnover
por: Mavrakis, Konstantinos J, et al.
Publicado: (2007) -
Buyang Huanwu Decoction protects against STZ-induced diabetic nephropathy by inhibiting TGF-β/Smad3 signaling-mediated renal fibrosis and inflammation
por: Wu, Weifeng, et al.
Publicado: (2021) -
Arkadia-SKI/SnoN signaling differentially regulates TGF-β–induced iTreg and Th17 cell differentiation
por: Xu, Hao, et al.
Publicado: (2021) -
The Protective Role of Smad7 in Diabetic Kidney Disease: Mechanism and Therapeutic Potential
por: Chen, Hai Yong, et al.
Publicado: (2011) -
Arkadia protein expression is reduced in the liver during the progression of hepatic fibrosis
por: Hou, Fei, et al.
Publicado: (2018)